Aller au contenu principal

 Articles scientifiques

Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study.

Auteurs : Baré M, Poeta S, Fernandes P, Jourani Y, Otte FX, Van Brussel S, Van Gestel D, Van den Begin R
Année : 2022
Journal : Phys Imaging Radiat Oncol
Volume : 23
Pages : 127-133

European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.

Auteurs : Andratschke N, Willmann J, Appelt AL, Alyamani N, Balermpas P, Baumert BG, Hurkmans C, Høyer M, Langendijk JA, Kaidar-Person O, van der Linden Y, Meattini I, Niyazi M, Reynaert N, De Ruysscher D, Tanadini-Lang S, Hoskin P, Poortmans P, Nieder C
Année : 2022
Journal : Lancet Oncol
Volume : 23
Pages : e469-e478

Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT.

Auteurs : Benkhaled S, Gomes da Silveira Cauduro C, Jullian N, Desmet A, Rodriguez D, Jourani Y, Van Gestel D, De Caluwé A
Année : 2022
Journal : Front Oncol
Volume : 12
Pages : 936088

The State of the Art of Radiotherapy for Non-melanoma Skin Cancer: A Review of the Literature.

Auteurs : Benkhaled S, Van Gestel D, Gomes da Silveira Cauduro C, Palumbo S, Del Marmol V, Desmet A
Année : 2022
Journal : Front Med (Lausanne)
Volume : 9
Pages : 913269

A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.

Auteurs : Zhang Z, Xie S, Cai W, Hong ZN, Yang C, Lin Y, Zhu J, Lin Z, Christoph DC, Bohnenberger H, Kepka L, Brueckl WM, Van Houtte P, Kang M, Lin J
Année : 2022
Journal : Transl Lung Cancer Res
Volume : 11
Pages : 75-86

Oligometastatic Disease Detection with <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.

Auteurs : Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P
Année : 2021
Journal : Cancers (Basel)
Volume : 13

Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literature.

Auteurs : Benkhaled S, Mané M, Jungels C, Shumelinsky F, de Saint-Aubain de Somerhausen N, Van Gestel D
Année : 2021
Journal : Cancer Treat Res Commun
Volume : 26
Pages : 100282

Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: Differences between tangential beam and VMAT.

Auteurs : Ahrouch I, Van Gestel D, Koshariuk O, Kirkove C, Desmet A, Philippson C, Reynaert N, De Caluwe A
Année : 2021
Journal : Radiother Oncol
Volume : 164
Pages : 282-288

The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.

Auteurs : Zilli T, Dirix P, Heikkilä R, Liefhooghe N, Siva S, Gomez-Iturriaga A, Everaerts W, Otte FX, Shelan M, Mercier C, Achard V, Thon K, Stellamans K, Moon D, Conde-Moreno A, Papachristofilou A, Scorsetti M, Gückenberger M, Ameye F, Zapatero A, Van De Voorde L, López Campos F, Couñago F, Jaccard M, Spiessens A, Semac I, Vanhoutte F, Goetghebeur E, Reynders D, Ost P
Année : 2021
Journal : Eur Urol Focus
Volume : 7
Pages : 241-244

Delineation guidelines for the lymphatic target volumes in 'prone crawl' radiotherapy treatment position for breast cancer patients.

Auteurs : Stouthandel MEJ, Kayser F, Vakaet V, Khoury R, Deseyne P, Monten C, Schoepen M, Remouchamps V, De Caluwe A, Janoray G, De Neve W, Mazy S, Veldeman L, Van Hoof T
Année : 2021
Journal : Sci Rep
Volume : 11
Pages : 22529

Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

Auteurs : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F
Année : 2021
Journal : Acta oncol (Stockholm)
Volume : 60
Pages : 549-553

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?

Auteurs : Navez J, Bouchart C, Lorenzo D, Bali MA, Closset J, Van Laethem JL
Année : 2021
Journal : Ann Surg Oncol
Volume : 28
Pages : 6211-6222

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of <sup>99m</sup>Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Auteurs : Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N
Année : 2021
Journal : EJNMMI Phys
Volume : 8
Pages : 9

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.

Auteurs : de Bakker T, Journe F, Descamps G, Saussez S, Dragan T, Ghanem G, Krayem M, Van Gestel D
Année : 2021
Journal : Front Oncol
Volume : 11
Pages : 799993

EUS-guided placement of fiducial markers for stereotactic body radiation therapy in pancreatic cancer: feasibility, security and a new quality score.

Auteurs : Figueiredo M, Bouchart C, Moretti L, Mans L, Engelholm JL, Bali MA, Van Laethem JL, Eisendrath P
Année : 2021
Journal : Endosc Int Open
Volume : 9
Pages : E253-E257

Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma.

Auteurs : Giraud P, Racadot S, Vernerey D, Goldstein D, Glimelius B, Van Houtte P, Gubanski M, Spry N, Van Laethem JL, Hammel P, Huguet F
Année : 2021
Journal : Int J Radiat Oncol Biol Phys
Volume : 110
Pages : 993-1002

Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma.

Auteurs : Schernberg A, Vernerey D, Goldstein D, Van Laethem JL, Glimelius B, Van Houtte P, Bonnetain F, Louvet C, Hammel P, Huguet F
Année : 2021
Journal : Int J Radiat Oncol Biol Phys
Volume : 110
Pages : 1022-1031

Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study.

Auteurs : Lallemand F, Leroi N, Blacher S, Bahri MA, Balteau E, Coucke P, Noël A, Plenevaux A, Martinive P
Année : 2021
Journal : Front Oncol
Volume : 11
Pages : 784437

Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency.

Auteurs : Kry SF, Lye J, Clark CH, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Filippo Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J
Année : 2021
Journal : Radiother Oncol
Volume : 159
Pages : 106-111

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment.

Auteurs : Vermorken JB, Van Gestel D
Année : 2021
Journal : Front Oncol
Volume : 11
Pages : 636622